News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ablexis Announces Licensing of the AlivaMab Mouse Technology to Another Major Pharmaceutical Company



7/10/2012 10:21:51 AM

SAN FRANCISCO--(BUSINESS WIRE)--Ablexis, LLC, a biotechnology company dedicated to developing the AlivaMab Mouse, an innovative platform for discovery of the next generation of breakthrough antibody drugs, today announced another non-exclusive license agreement with a top 20 global pharmaceutical company. This announced agreement follows the announcement in 2010 of the Ablexis pharma consortium, non-exclusive licensing agreements with five of the top 20 global pharmaceutical companies.

Read at BioSpace.com


comments powered by Disqus
Ablexis
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES